JP2017513826A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017513826A5 JP2017513826A5 JP2016560695A JP2016560695A JP2017513826A5 JP 2017513826 A5 JP2017513826 A5 JP 2017513826A5 JP 2016560695 A JP2016560695 A JP 2016560695A JP 2016560695 A JP2016560695 A JP 2016560695A JP 2017513826 A5 JP2017513826 A5 JP 2017513826A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- group
- substituted
- composition
- aryl group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461973994P | 2014-04-02 | 2014-04-02 | |
| US61/973,994 | 2014-04-02 | ||
| PCT/US2015/023883 WO2015153761A2 (en) | 2014-04-02 | 2015-04-01 | Macrocyclic peptidomimetics for alpha-helix mimicry |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017513826A JP2017513826A (ja) | 2017-06-01 |
| JP2017513826A5 true JP2017513826A5 (https=) | 2018-05-17 |
| JP6642887B2 JP6642887B2 (ja) | 2020-02-12 |
Family
ID=54241434
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016560695A Expired - Fee Related JP6642887B2 (ja) | 2014-04-02 | 2015-04-01 | アルファヘリックスを模倣した大環状ペプチドミメティック |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US10294273B2 (https=) |
| EP (1) | EP3126375B1 (https=) |
| JP (1) | JP6642887B2 (https=) |
| CN (1) | CN106604928A (https=) |
| CA (1) | CA2944651A1 (https=) |
| WO (1) | WO2015153761A2 (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10827064B2 (en) | 2016-06-13 | 2020-11-03 | Google Llc | Automated call requests with status updates |
| EP3748558A1 (en) * | 2016-06-13 | 2020-12-09 | Google LLC | Automated telephone call initiating system and method |
| US11479581B2 (en) | 2017-06-09 | 2022-10-25 | Bristol-Myers Squibb Company | Non-chromatographic purification of macrocyclic peptides by a resin catch and release |
| WO2018232062A1 (en) | 2017-06-15 | 2018-12-20 | University Of Washington | Macrocyclic polypeptides |
| CA3078504A1 (en) | 2017-10-04 | 2019-04-11 | Ohio State Innovation Foundation | Bicyclic peptidyl inhibitors |
| CN117567639A (zh) * | 2017-10-27 | 2024-02-20 | 俄亥俄州国家创新基金会 | 用于细胞内递送装订肽的多肽缀合物 |
| WO2019148195A2 (en) | 2018-01-29 | 2019-08-01 | Ohio State Innovation Foundation | Cyclic peptidyl inhibitors of cal-pdz binding domain |
| US11987647B2 (en) | 2018-05-09 | 2024-05-21 | Ohio State Innovation Foundation | Cyclic cell-penetrating peptides with one or more hydrophobic residues |
| WO2020227313A1 (en) | 2019-05-06 | 2020-11-12 | Google Llc | Automated calling system |
| US11158321B2 (en) | 2019-09-24 | 2021-10-26 | Google Llc | Automated calling system |
| EP3909230B1 (en) | 2020-03-20 | 2024-10-23 | Google LLC | Semi-delegated calling by an automated assistant on behalf of human participant |
| US11303749B1 (en) | 2020-10-06 | 2022-04-12 | Google Llc | Automatic navigation of an interactive voice response (IVR) tree on behalf of human user(s) |
| CN118829648A (zh) * | 2021-12-10 | 2024-10-22 | 默沙东有限责任公司 | P53拟肽大环化合物 |
| TW202417465A (zh) | 2022-08-23 | 2024-05-01 | 日商富士軟片股份有限公司 | 環肽或其鹽及ｍｄｍｘ抑制劑 |
| WO2024054892A1 (en) * | 2022-09-09 | 2024-03-14 | Shape Therapeutics Inc. | Therapeutic peptides |
| US12225158B2 (en) | 2022-12-15 | 2025-02-11 | Google Llc | System(s) and method(s) for implementing a personalized chatbot |
| JP2026504093A (ja) | 2023-01-16 | 2026-02-03 | アンブレツクス・インコーポレイテツド | 抗ｃｄ７０抗体薬物コンジュゲート |
| US12581015B2 (en) | 2023-03-21 | 2026-03-17 | Google Llc | Automating telephone call(s) on behalf of user(s) |
| WO2024241086A1 (en) | 2023-05-24 | 2024-11-28 | Ambrx, Inc. | Pegylated bovine interferon lambda and methods of use thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7083983B2 (en) | 1996-07-05 | 2006-08-01 | Cancer Research Campaign Technology Limited | Inhibitors of the interaction between P53 and MDM2 |
| WO2005090388A1 (en) * | 2004-03-19 | 2005-09-29 | The University Of Queensland | Alpha helical mimics, their uses and methods for their production |
| BRPI0720306A2 (pt) * | 2006-12-14 | 2014-02-04 | Aileron Therapeutics Inc | Sistemas de macrociclização da bis-sufidrila |
| DE112009000300T5 (de) * | 2008-02-08 | 2011-01-20 | Aileron Therapeutics, Inc., Cambridge | Therapeutische Peptidomimetische Makrocyclen |
| WO2009149339A2 (en) * | 2008-06-05 | 2009-12-10 | University Of Maryland, Baltimore | P53 activator peptides |
| CN102203126A (zh) * | 2008-09-22 | 2011-09-28 | 爱勒让治疗公司 | 用于制备纯化的多肽组合物的方法 |
| US9175047B2 (en) * | 2009-01-14 | 2015-11-03 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
| CN102712675A (zh) * | 2009-09-22 | 2012-10-03 | 爱勒让治疗公司 | 拟肽大环化合物 |
| ES2711526T3 (es) * | 2010-08-13 | 2019-05-06 | Aileron Therapeutics Inc | Macrociclos peptidomiméticos |
| WO2012083078A2 (en) * | 2010-12-15 | 2012-06-21 | The Research Foundation Of State University Of New York | Croos-linked peptides and proteins, methods of making same, and uses thereof |
| WO2012100176A2 (en) * | 2011-01-20 | 2012-07-26 | University Of Rochester | Macrocyclic compounds with a hybrid peptidic/non-peptidic backbone and methods for their preparation |
-
2015
- 2015-04-01 EP EP15773413.8A patent/EP3126375B1/en active Active
- 2015-04-01 WO PCT/US2015/023883 patent/WO2015153761A2/en not_active Ceased
- 2015-04-01 CA CA2944651A patent/CA2944651A1/en not_active Abandoned
- 2015-04-01 JP JP2016560695A patent/JP6642887B2/ja not_active Expired - Fee Related
- 2015-04-01 US US15/301,084 patent/US10294273B2/en active Active
- 2015-04-01 CN CN201580029301.XA patent/CN106604928A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017513826A5 (https=) | ||
| FI3694529T3 (fi) | Trispesifiset proteiinit ja niiden käyttömenetelmät | |
| ES2387685T3 (es) | Péptido WT1 restringido por HLA-A*3303 y composición farmacéutica que comprende el mismo | |
| US10077294B2 (en) | Peptide inhibitors of TEAD/YAP-TAZ interaction | |
| RU2018131636A (ru) | Новые конъюгаты аманитина | |
| PE20180505A1 (es) | Peptidos y combinacion de peptidos y andamiajes novedosos para su uso en inmunoterapia contra carcinoma de celulas renales (rcc) y otros canceres | |
| CY1117437T1 (el) | Αντισωματα αντι-μεσοθηλινης και χρησεις αυτων | |
| RU2007136026A (ru) | Варианты ил-21 | |
| JP2019501141A5 (https=) | ||
| EA201590986A1 (ru) | Антитела к ceacam5 и их применения | |
| MX2020000413A (es) | Una vacuna universal basada en neoantigenos de tumor compartidos para prevencion y tratamiento de canceres inestables de microsatelite (msi). | |
| JP2013121977A5 (https=) | ||
| JP2015522264A5 (https=) | ||
| WO2020022898A3 (en) | Off-the-shelf cancer vaccines | |
| NZ723940A (en) | Beta-substituted beta-amino acids and analogs as chemotherapeutic agents | |
| BR112012025567A2 (pt) | peptídeos de cdca5 e vacinas que incluem os mesmos | |
| JP2018507689A5 (https=) | ||
| JP2021536239A5 (https=) | ||
| FI3335725T3 (fi) | Pds5a-epitooppeja immuuniteetin indusoijina | |
| CN108452322A (zh) | 基于长链非编码rna的bcl2基因抑制剂 | |
| CN112739381A (zh) | 使用了hsp47的抑制物质的癌转移抑制 | |
| EA201291004A1 (ru) | Пептиды ect2 и включающие их вакцины | |
| AR113982A1 (es) | Péptido antagonista de la actividad de la interleucina-15 | |
| EP2545171A4 (en) | HJURP PEPTIDES AND VACCINES CONTAINING THEM | |
| SG10201408245WA (en) | Tmem22 peptides and vaccines including the same |